AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
From MaRDI portal
Publication:3506537
DOI10.1137/060665294zbMath1357.49086OpenAlexW2004710504WikidataQ126232599 ScholiaQ126232599MaRDI QIDQ3506537
Urszula Łedzewicz-Kowalewska, Heinz Schättler
Publication date: 16 June 2008
Published in: SIAM Journal on Control and Optimization (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1137/060665294
Dynamical systems in biology (37N25) Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15)
Related Items
Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy ⋮ Discretization of semilinear bang-singular-bang control problems ⋮ Tangency property and prior-saturation points in minimal time problems in the plane ⋮ Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model ⋮ Optimal control of vibration-based micro-energy harvesters ⋮ Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity ⋮ An optimal control approach for the treatment of solid tumors with angiogenesis inhibitors ⋮ Local controllability and optimal control for a model of combined anticancer therapy with control delays ⋮ On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach ⋮ Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment ⋮ A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy ⋮ The Structure of Optimal Protocols for a Mathematical Model of Chemotherapy with Antiangiogenic Effects ⋮ Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth ⋮ Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy ⋮ Unnamed Item ⋮ A numerical method for nonconvex multi-objective optimal control problems ⋮ The nature of Hopf bifurcation for the Gompertz model with delays ⋮ Robust optimal control of logical control networks with function perturbation ⋮ Structural stability investigation of bang-singular-bang optimal controls ⋮ Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments ⋮ Fractional neutral stochastic integrodifferential equations with Caputo fractional derivative: Rosenblatt process, Poisson jumps and Optimal control ⋮ An optimization method for treating solid tumors with combined therapy using the great deluge algorithm ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays ⋮ Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem ⋮ Stability analysis of the family of tumour angiogenesis models with distributed time delays ⋮ On an extension of a mathematical model for tumor anti-angiogenesis ⋮ Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent ⋮ Stability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancer ⋮ A dynamic programming approach for approximate optimal control for cancer therapy ⋮ Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System ⋮ Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia ⋮ Closed-loop control of tumor growth by means of anti-angiogenic administration ⋮ Ebola model and optimal control with vaccination constraints ⋮ Delay Differential Equations in Bio-Populations ⋮ Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control ⋮ Optimal combined radio- and anti-angiogenic cancer therapy ⋮ Analysis of an optimal control problem connected to bioprocesses involving a saturated singular arc ⋮ Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics ⋮ Global solvability and optimal control to a haptotaxis cancer invasion model with two cancer cell species ⋮ Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors ⋮ Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth ⋮ Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models ⋮ On the role of the objective in the optimization of compartmental models for biomedical therapies ⋮ On the role of pharmacometrics in mathematical models for cancer treatments ⋮ Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers ⋮ Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors ⋮ Dynamical modeling and optimal control of landfills ⋮ Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis ⋮ On probabilistic certification of combined cancer therapies using strongly uncertain models ⋮ Dynamics and control of a mathematical model for metronomic chemotherapy ⋮ Tumor Development Under Combination Treatments with Anti-angiogenic Therapies ⋮ Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design ⋮ Transition therapy: tackling the ecology of tumor phenotypic plasticity ⋮ On optimal delivery of combination therapy for tumors ⋮ Pitfalls in applying optimal control to dynamical systems: an overview and editorial perspective ⋮ Multiobjective approach in the treatment of cancer ⋮ Optimal control for a mathematical model for chemotherapy with pharmacometrics ⋮ Optimal control and pattern formation for a haptotaxis model of solid tumor invasion ⋮ Numerical solution for a problem arising in angiogenic signalling ⋮ Periodic solutions for a model of tumor volume with anti-angiogenic periodic treatment
